Average Co-Inventor Count = 4.41
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (9 from 4,945 patents)
2. Janssen Sciences Ireland Unlimited Company (1 from 60 patents)
3. F. Hoffmann-la Roche Ag (168 patents)
10 patents:
1. 11225482 - Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
2. 11124495 - Tetrahydroisoquinolines and terahydronaphthyridines for the treatment of hepatitis B virus infection
3. 11104674 - Tetrahydropyridopyrimidines for the treatment of HBV infection
4. 11053235 - Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases
5. 10968217 - Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
6. 10968218 - Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
7. 10336751 - Tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection
8. 10196391 - Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection
9. 10150740 - 6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection
10. 9845322 - Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection